Keyphrases
Particle-based
100%
Virus-like
100%
Vaccine Antigen
26%
B Cells
13%
Self-tolerance
13%
Particle System
13%
Capsid Protein
13%
Particulate
6%
Acinetobacter
6%
High Efficacy
6%
Generic Tool
6%
Vaccination
6%
Efficient Development
6%
Rapid Methods
6%
Pfs25
6%
Subunit Vaccine
6%
Antibody Response
6%
Interleukin-5 (IL-5)
6%
C-terminus
6%
Immunogenic
6%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
6%
Particle-bound
6%
Non-communicable Diseases
6%
Programmed Death-ligand 1 (PD-L1)
6%
Trial-and-error
6%
VAR2CSA
6%
Phage
6%
Particle Components
6%
Self-antigens
6%
Genetic Fusion
6%
Non-aggregated
6%
Conjugated System
6%
Occupancy
6%
Binding Site
6%
High Safety
6%
Immune System
6%
N-terminus
6%
Oligomeric Proteins
6%
Infectious Diseases
6%
Antibody Titer
6%
Coupling Efficiency
6%
Allergy
6%
Self-induced
6%
Malaria
6%
Immunology and Microbiology
Virus-Like Particle
100%
Virus Like Particle Vaccine
25%
Antibody Response
16%
Immune Tolerance
16%
Capsid
16%
B Cell
16%
Antibody Titer
8%
Immune System
8%
Subunit Vaccine
8%
Carboxy Terminal Sequence
8%
Acinetobacter
8%
Amino Terminal Sequence
8%
CTLA-4
8%
Infectious Disease
8%
Bacteriophage
8%
Interleukin 5
8%
Binding Site
8%
Programmed Death-Ligand 1
8%
Medicine and Dentistry
Virus Like Agent
100%
Capsid Protein
16%
Programmed Death-Ligand 1
8%
Acinetobacter
8%
Intein
8%